These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 21052933)

  • 1. How to overcome retinal neuropathy: the fight against angiogenesis-related blindness.
    Jo DH; Kim JH; Kim JH
    Arch Pharm Res; 2010 Oct; 33(10):1557-65. PubMed ID: 21052933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosmarinic acid suppresses retinal neovascularization via cell cycle arrest with increase of p21(WAF1) expression.
    Kim JH; Lee BJ; Kim JH; Yu YS; Kim MY; Kim KW
    Eur J Pharmacol; 2009 Aug; 615(1-3):150-4. PubMed ID: 19470386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Angiogenesis and inhibition of angiogenesis in the eye].
    Cursiefen C; Schönherr U
    Klin Monbl Augenheilkd; 1997 Jun; 210(6):341-51. PubMed ID: 9333658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibiting angiogenesis in retinoblastoma.
    Apte RS; Harbour JW
    Ophthalmic Res; 2007; 39(4):188-90. PubMed ID: 17556838
    [No Abstract]   [Full Text] [Related]  

  • 6. Müller cell-derived VEGF is a significant contributor to retinal neovascularization.
    Bai Y; Ma JX; Guo J; Wang J; Zhu M; Chen Y; Le YZ
    J Pathol; 2009 Dec; 219(4):446-54. PubMed ID: 19768732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predominant cone photoreceptor dysfunction in a hyperglycaemic model of non-proliferative diabetic retinopathy.
    Alvarez Y; Chen K; Reynolds AL; Waghorne N; O'Connor JJ; Kennedy BN
    Dis Model Mech; 2010; 3(3-4):236-45. PubMed ID: 20142328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herbimycin A inhibits angiogenic activity in endothelial cells and reduces neovascularization in a rat model of retinopathy of prematurity.
    McCollum GW; Rajaratnam VS; Bullard LE; Yang R; Penn JS
    Exp Eye Res; 2004 May; 78(5):987-95. PubMed ID: 15051479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Angioproliferative retinal disease caused by ischemia].
    Agostini HT; Hansen LL
    Ophthalmologe; 2003 May; 100(5):371-7. PubMed ID: 12748802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spare the rod and spoil the eye.
    Arden GB; Sidman RL; Arap W; Schlingemann RO
    Br J Ophthalmol; 2005 Jun; 89(6):764-9. PubMed ID: 15923516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferative retinopathies: angiogenesis that blinds.
    Sapieha P; Hamel D; Shao Z; Rivera JC; Zaniolo K; Joyal JS; Chemtob S
    Int J Biochem Cell Biol; 2010 Jan; 42(1):5-12. PubMed ID: 19836461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy.
    McLeod DS; Taomoto M; Cao J; Zhu Z; Witte L; Lutty GA
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):474-82. PubMed ID: 11818393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homoisoflavanone inhibits retinal neovascularization through cell cycle arrest with decrease of cdc2 expression.
    Kim JH; Kim KH; Kim JH; Yu YS; Kim YM; Kim KW; Kwon HJ
    Biochem Biophys Res Commun; 2007 Nov; 362(4):848-52. PubMed ID: 17803958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressed expression of tubedown-1 in retinal neovascularization of proliferative diabetic retinopathy.
    Gendron RL; Good WV; Adams LC; Paradis H
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):3000-7. PubMed ID: 11687548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity.
    Stone J; Chan-Ling T; Pe'er J; Itin A; Gnessin H; Keshet E
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):290-9. PubMed ID: 8603833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-angiogenic effect of caffeic acid on retinal neovascularization.
    Kim JH; Lee BJ; Kim JH; Yu YS; Kim KW
    Vascul Pharmacol; 2009 Oct; 51(4):262-7. PubMed ID: 19589397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technology evaluation: pegaptanib, Eyetech/Pfizer.
    Vinores SA
    Curr Opin Mol Ther; 2003 Dec; 5(6):673-9. PubMed ID: 14755895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease.
    Vinores SA; Youssri AI; Luna JD; Chen YS; Bhargave S; Vinores MA; Schoenfeld CL; Peng B; Chan CC; LaRochelle W; Green WR; Campochiaro PA
    Histol Histopathol; 1997 Jan; 12(1):99-109. PubMed ID: 9046048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MEF2C ablation in endothelial cells reduces retinal vessel loss and suppresses pathologic retinal neovascularization in oxygen-induced retinopathy.
    Xu Z; Gong J; Maiti D; Vong L; Wu L; Schwarz JJ; Duh EJ
    Am J Pathol; 2012 Jun; 180(6):2548-60. PubMed ID: 22521302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic profiling of human retinal and choroidal endothelial cells reveals molecular heterogeneity related to tissue of origin.
    Zamora DO; Riviere M; Choi D; Pan Y; Planck SR; Rosenbaum JT; David LL; Smith JR
    Mol Vis; 2007 Oct; 13():2058-65. PubMed ID: 18079679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.